期刊文献+

疏肝健脾法联合化疗治疗晚期乳腺癌临床研究 被引量:11

Clinical Study of the Therapy for Smoothing Liver Qi and strengthening Spleen Combined with Chemotherapy in the Treatment of Advanced Breast Cancer Patients
下载PDF
导出
摘要 目的探讨疏肝健脾中药联合化疗治疗晚期乳腺癌患者的临床疗效。方法将73例IV期乳腺癌住院患者,随机分为两组,其中治疗组37例,对照组36例,两组均给予GC方案化疗,治疗组加服逍遥散加减方治疗。连续观察2个化疗周期,观察两周期后两组的近期疗效、中医证候改善情况、毒副作用、KPS评分情况、肿瘤标志物。结果治疗组治疗后有效率和稳定率分别为37.8%和78.4%,对照组分别为36.1%和72.2%;两组患者中医证候总评分比较差异无统计学意义,但治疗组在改善腹胀、胁肋胀痛方面有效率优于对照组(P<0.01,P<0.05)。治疗组Ⅳ度消化道反应发生率明显低于对照组(P<0.05)。治疗组肿瘤标志物CEA、CA153改善情况较对照组明显(P<0.01,P<0.05)。治疗组治疗后KPS评分高于对照组(P<0.05)。结论疏肝健脾法可提高乳腺癌患者的生活质量,减轻化疗药物的消化道副作用。 Objective To explore the clinical efficacy on advanced breast cancer treated with the herbal medicine for smoothing liver qi and strengthening spleen combined with chemotherapy( combined therapy). Methods Seventy- three inpatients of breast cancer of IV stage were randomly divided into a treatment group( n = 37,) and a control group( n = 36). GC chemotherapy was applied in the two groups. In the treatment group,the modified xiaoyao san was added. The observation was done continuously for 2 cycles of chemotherapy. The short- term effect,TCM syndromes,toxic side effects,KPS score and tumor markers were observed. Results The effective rate was 37. 8% and the stable rate was 78. 4% in the treatment group and was 36. 1% and 72. 2% in the control group respectively. There was no statistical difference in the total scores of TCM syndrome between the two groups. But the effective rates for the improvements in abdominal distending pain and distending pain in the hypochondriac region were higher than those of the control group( P < 0. 01,P < 0. 05). The incidence rate of IV degree gastrointestinal reaction was lower than that of the control group( P < 0. 05). The improvements in CEA and CA153 were apparent as compared with the control group( P < 0. 01,P < 0. 05). KPS score in the treatment group was higher than that of the control group after treatment( P < 0. 05). Conclusions The therapy for smoothing liver qi and strengthening spleen improves the quality of life for advanced breast cancer patients,and alleviate gastrointestinal side effects induced by chemotherapy.
出处 《世界中西医结合杂志》 2016年第6期815-818,共4页 World Journal of Integrated Traditional and Western Medicine
基金 国家自然科学基金(81503517)
关键词 乳腺癌 化疗 疏肝健脾 生活质量 Breast Cancer Chemotherapy Smoothing Liver Qi and Strengthening Spleen Quality of Life
  • 相关文献

参考文献8

二级参考文献32

  • 1王华庆,张会来,方志沂.晚期转移性乳腺癌的化疗新进展[J].国外医学(肿瘤学分册),2005,32(9):684-686. 被引量:10
  • 2徐咏梅,杨国旺,王笑民,韩冬,于洁,赵文硕.丹栀逍遥散加减治疗乳腺癌内分泌综合征65例临床观察[J].河北中医,2005,27(9):676-676. 被引量:19
  • 3汤睿,朱正纲.凋亡途径与肿瘤治疗[J].世界华人消化杂志,2005,13(20):2469-2472. 被引量:27
  • 4荣素英,李君,牛风玲,张国志,姚三巧.唐山地区女性乳腺癌环境危险因素的病例对照研究[J].环境与职业医学,2007,24(1):5-8. 被引量:4
  • 5管忠震,梅尉德.肿瘤内科诊治手册[M].合肥:安徽科学技术出版社,2006:64,66.
  • 6[1]Heinemann V. Gemcitabine plus cisplatin for the treatment of metastatic breast cancer[ J]. Clin Breast Cancer,2002,3 (Suppl 1 ): S24-S29.
  • 7[2]Seidman AD. Gemcitabine as single-agent therapy in the management of advanced breast cancer [ J ]. Oncology, 2001,15(2) (Suppl 3): 11-14.
  • 8[3]Jurga L,Misurova E, Kovac V, et al. The role of cisplatin in chemotherapy of advanced breast cancer[J]. Neoplasma, 1994,41 ( 6 ) :347-352.
  • 9[4]Carmichael J, Walling J. Advanced breast cancer:investigational role of gemcitabine[ J]. Eur J Cancer, 1997,33( Suppl 1 ): S27-S31.
  • 10[5]Pegram MD, Lipton A, Hayes DF, et al. Phase Ⅱ study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment [ J ]. J Clin Oncol, 1998, 16(8) :2659-2671.

共引文献95

同被引文献168

引证文献11

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部